Skip to main content

Table 1 Comparative statistics of routine laboratory tests between the patientsā€™ group and the control group using Wilcoxon rank sum test

From: Study of the association between GLIS3 rs10758593 and type 2 diabetes mellitus in Egyptian population

Parameter

Group I T2DM patients (nā€‰=ā€‰100)

Group II control (nā€‰=ā€‰100)

z value

p value

Sig.

Age (years)

Median (IQR)

52 (46ā€“58)

52 (45.25ā€“58)

āˆ’ā€‰0.257

0.797

NS

BMI

Median (IQR)

29 (27ā€“31)

28.05 (25.7ā€“30.95)

āˆ’ā€‰2.029

0.042

S

HbA1c (%)

Median (IQR)

8.1 (7.2ā€“9.775)

5.3 (4.8ā€“5.4)

āˆ’ā€‰12.23

<ā€‰0.001

HS

Fasting blood glucose (mg/dL)

Median (IQR)

188.5 (136.5ā€“242.75)

88 (83ā€“92)

āˆ’ā€‰12.158

<ā€‰0.001

HS

Fasting insulin (mIU/L)

Median (IQR)

15 (12ā€“20)

6 (4ā€“8)

āˆ’ā€‰11.147

<ā€‰0.001

HS

HOMA-IR

Median (IQR)

7.41 (4.69ā€“10.45)

1.25 (0.91ā€“1.81)

āˆ’ā€‰12.122

<ā€‰0.001

HS

  1. IQR interquartile range, p value probability, BMI Body mass index, T2DM type 2 diabetes mellitus, HbA1C glycated hemoglobin, HOMA-IR homeostatic model assessment for insulin resistance, n number, NS non-significant, S Significant, HS highly significant